← All organizations

Serum Life Science Europe GmbH

For profitWebsite ↗

Also known as: Serum Life Science Europe GmbH

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 29, 2025

Timeline

2000s

Jan 1, 2002
Serum Life Science Europe GmbH— Founded

Drugs by trial phase (3 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

20-valent pneumococcal conjugate vaccine

Recent trials (2)

NCT07216430Lead sponsorPhase 2Sep 29, 2025
NCT07059182Lead sponsorPhase 1Jun 11, 2025

Details

Founded: Hannover, DE Jan 1, 2002
Last known activity: Sep 29, 2025